Showing results (221-230 of 256) with videos related to
Sort By:
Pageof 26
Scandinavian Journal of Urology and Nephrology|October 26, 2001
Tumor grade heterogeneity in urothelial bladder carcinoma--proposal of a system using combined numbersA Billis, R B Carvalho, A C Mattos, et al.International Journal of Biological Macromolecules|January 30, 2026
Exploring the multifunctional potential of tannic acid-crosslinked Wharton's jelly hydrogel as a scaffold for bone regenerative medicineL Scomazzon, L Adam, A Lavrand, et al.The Journal of Pharmacology and Experimental Therapeutics|March 30, 2011
Preclinical pharmacology of AZD2327: a highly selective agonist of the δ-opioid receptorT J Hudzik, C Maciag, M A Smith, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.Malaysian Family Physician : the Official Journal of the Academy of Family Physicians of Malaysia|March 17, 2020
Management of diabetes in pregnancy in primary careM N Nurain, L Z Marmuji, I Mastura, et al.The Medical Journal of Malaysia|July 30, 2020
Management of prediabetes in Malaysian population: An experts' opinionM Mafauzy, E M Khoo, Z Hussein, et al.Reproduction, Fertility, and Development|July 22, 2016
Epigenetics and developmental programming of welfare and production traits in farm animalsK D Sinclair, K M D Rutherford, J M Wallace, et al.Science (New York, N.Y.)|December 16, 2000
Arabidopsis transcription factors: genome-wide comparative analysis among eukaryotesJ L Riechmann, J Heard, G Martin, et al.SLAS Discovery : Advancing Life Sciences R & D|June 12, 2023
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosinJ M Muretta, D Rajasekaran, Y Blat, et al.Pharmacological Reports : PR|April 9, 2018
Selective cytotoxic and genotoxic activities of 5-(2-bromo-5-methoxybenzylidene)-thiazolidine-2,4-dione against NCI-H292 human lung carcinoma cellsMaria do D Rodrigues, Priscila B G S Santiago, Karla M R Marques, et al.Pageof 26